Literature DB >> 12840961

Drug interaction management.

Philip D Hansten1.   

Abstract

Although thousands of articles on drug interactions have been published and numerous computerized screening systems have been developed, patients continue to suffer from adverse drug interactions. Possible methods for reducing the risk of drug interactions include improving the knowledge of health care providers, improving computerized screening systems, providing information on patient risk factors, increased use of pharmacogenetic information, more attention to drug administration risk factors, and improving patient education on drug interactions.

Entities:  

Mesh:

Year:  2003        PMID: 12840961     DOI: 10.1023/a:1024077018902

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  22 in total

1.  Clinical relevance of drug-drug interactions : a structured assessment procedure.

Authors:  Eric N van Roon; Sander Flikweert; Marianne le Comte; Pim N J Langendijk; Wilma J M Kwee-Zuiderwijk; Paul Smits; Jacobus R B J Brouwers
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

2.  Management of potential drug interactions in community pharmacies: a questionnaire-based survey in Switzerland.

Authors:  Jörg Indermitte; Laura Erba; Marianne Beutler; Rudolf Bruppacher; Walter E Haefeli; Kurt E Hersberger
Journal:  Eur J Clin Pharmacol       Date:  2007-01-11       Impact factor: 2.953

3.  Checklist for standardized reporting of drug-drug interaction management guidelines.

Authors:  Annemieke Floor-Schreudering; Arjen F J Geerts; Jeffrey K Aronson; Marcel L Bouvy; Robin E Ferner; Peter A G M De Smet
Journal:  Eur J Clin Pharmacol       Date:  2013-12-05       Impact factor: 2.953

4.  Clarity and applicability of drug-drug interaction management guidelines: a systematic appraisal by general practitioners and community pharmacists in the Netherlands.

Authors:  Annemieke Floor-Schreudering; Peter A G M De Smet; Henk Buurma; Sonia Amini; Marcel L Bouvy
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

5.  Detection of potential drug interactions - a model for a national pharmacy register.

Authors:  Bengt Astrand; Emelie Astrand; Karolina Antonov; Göran Petersson
Journal:  Eur J Clin Pharmacol       Date:  2006-07-29       Impact factor: 2.953

6.  Statin-macrolide interaction risk: a population-based study throughout a general practice database.

Authors:  Nadia Piacentini; Gianluca Trifiró; Michele Tari; Salvatore Moretti; Vincenzo Arcoraci
Journal:  Eur J Clin Pharmacol       Date:  2005-07-26       Impact factor: 2.953

7.  Identification of severe potential drug-drug interactions using an Italian general-practitioner database.

Authors:  L Magro; A Conforti; F Del Zotti; R Leone; M L Iorio; I Meneghelli; D Massignani; E Visonà; U Moretti
Journal:  Eur J Clin Pharmacol       Date:  2007-11-09       Impact factor: 2.953

8.  Comparative performance of two drug interaction screening programmes analysing a cross-sectional prescription dataset of 84,625 psychiatric inpatients.

Authors:  Olesya I Zorina; Patrick Haueis; Waldemar Greil; Renate Grohmann; Gerd A Kullak-Ublick; Stefan Russmann
Journal:  Drug Saf       Date:  2013-04       Impact factor: 5.606

9.  Assessment of Drug-Drug Interactions among Renal Failure Patients of Nephrology Ward in a South Indian Tertiary Care Hospital.

Authors:  Mylapuram Rama; Gayathri Viswanathan; Leelavathi D Acharya; R P Attur; P N Reddy; S V Raghavan
Journal:  Indian J Pharm Sci       Date:  2012-01       Impact factor: 0.975

10.  Computing with evidence Part I: A drug-mechanism evidence taxonomy oriented toward confidence assignment.

Authors:  Richard Boyce; Carol Collins; John Horn; Ira Kalet
Journal:  J Biomed Inform       Date:  2009-05-10       Impact factor: 6.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.